On the contrary, GAL3 treatment downregulates the inflammatory signaling pathway, exerting a protective effect in conditions like stroke in rats, thereby mitigating apoptosis and neurodegeneration (Wesley et al., 2021). This evidence concerns the gene LGALS3 and Stroke.